Hemodynamic optimization of sepsis-induced tissue hypoperfusion

Critical Care

Volumn 10, Issue SUPPL. 3, 2006, Pages

  Zanotti Cavazzoni, Sergio L ^a   Dellinger, R Phillip ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALBUMIN; DOBUTAMINE; DOPAMINE; DOPEXAMINE; HYPERTENSIVE AGENT; INOTROPIC AGENT; NORADRENALIN; PHENYLEPHRINE; SODIUM CHLORIDE; VASOPRESSIN; BIOLOGICAL MARKER; CARDIOTONIC AGENT; OXYGEN; VASOCONSTRICTOR AGENT;

ARTIFICIAL VENTILATION; BLOOD PRESSURE; BLOOD TRANSFUSION; CARDIOGENIC SHOCK; CENTRAL VENOUS PRESSURE; CLINICAL TRIAL; DIAGNOSTIC VALUE; DOSE RESPONSE; DRUG MECHANISM; EARLY INTERVENTION; ERYTHROCYTE TRANSFUSION; FLUID RESUSCITATION; FLUID THERAPY; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEMODYNAMIC MONITORING; HEMODYNAMICS; HUMAN; HYPOVOLEMIA; ISCHEMIA; KIDNEY FAILURE; LOW DRUG DOSE; MEAN ARTERIAL PRESSURE; NONHUMAN; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PULMONARY ARTERY CATHETER; RENAL PROTECTION; RESUSCITATION; REVIEW; SEPSIS; SEPTIC SHOCK; TACHYCARDIA; TISSUE PERFUSION; TREATMENT OUTCOME; BLOOD VOLUME; CIRCULATION; INTENSIVE CARE; METABOLISM; METHODOLOGY; MONITORING;

BIOLOGICAL MARKERS; BLOOD CIRCULATION; BLOOD PRESSURE; BLOOD TRANSFUSION; BLOOD VOLUME; CARDIOTONIC AGENTS; CRITICAL CARE; FLUID THERAPY; HUMANS; MONITORING, PHYSIOLOGIC; OXYGEN; SEPSIS; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS;

EID: 36048933359     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc4829     Document Type: Review

References (51)

1. Angus DC Linde-Zwirble WT Lidicker J Clermont G Carcillo J Pinsky MR Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care Crit Care Med 2001, 29:1303-1310. 10.1097/00003246-200107000-00002 11445675
2. Dellinger RP Cardiovascular management of septic shock Crit Care Med 2003, 31:946-955. 10.1097/01.CCM.0000057403.73299.A6 12627010
3. Sessler CN Perry JC Varney KL Management of severe sepsis and septic shock Curr Opin Crit Care 2004, 10:354-363. 10.1097/ 01.ccx.0000139363.76068.7b 15385751
4. Bochud PY Calandra T Pathogenesis of sepsis: New concepts and implications for future treatment BMJ 2003, 326:262-266. 1125122 12560281 10.1136/bmj.326.7383.262
5. Hotchkiss RS Karl IE The pathophysiology and treatment of sepsis N Engl J Med 2003, 348:138-150. 10.1056/NEJMra021333 12519925
6. Parrillo JE Parker MM Natanson C Suffredini AF Danner RL Cunnion RE Ognibene FP Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy Ann Intern Med 1990, 113:227-242. 2197912
7. Rivers E Nguyen B Havstad S Ressler J Muzzin A Knoblich B Peterson E Tomlanovich M Early Goal-Directed Therapy Collaborative Group Early goal-directed therapy in the treatment of severe sepsis and septic shock N Engl J Med 2001, 345:1368-1377. 10.1056/NEJMoa010307 11794169
8. Levy MM Fink MP Marshall JC Abraham E Angus D Cook D Cohen J Opal SM Vincent JL Ramsay G SCCM/ESICM/ACCP/ATS/SIS 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference Crit Care Med 2003, 31:1250-1256. 10.1097/01.CCM.0000050454.01978.3B 12682500
9. Hollenberg SM Ahrens TS Annane D Astiz ME Chalfin DB Dasta JF Heard SO Martin C Napolitano LM Susla GM et al.: Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update Crit Care Med 2004, 32:1928-1948. 10.1097/01.CCM.0000139761.05492.D6 15343024
10. Michard F Boussat S Chemla D Anguel N Mercat A Lecarpentier Y Richard C Pinsky MR Teboul JL Relation between respiratory changes in arterial pulse pressure and fluid responsiveness in septic patients with acute circulatory failure Am J Respir Crit Care Med 2000, 162:134-138. 10903232
11. Michard F Teboul JL Predicting fluid responsiveness in ICU patients: A critical analysis of the evidence Chest 2002, 121:2000-2008. 10.1378/ chest.121.6.2000 12065368
12. LeDoux D Astiz ME Carpati CM Rackow EC Effects of perfusion pressure on tissue perfusion in septic shock Crit Care Med 2000, 28:2729-2732. 10.1097/00003246-200008000-00007 10966242
13. Dellinger RP Carlet JM Masur H Gerlach H Calandra T Cohen J Gea-Banacloche J Keh D Marshall JC Parker MM et al.: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock Crit Care Med 2004, 32:858-873. 10.1097/01.CCM.0000117317.18092.E4 15090974
14. Dellinger RP Carlet JM Gerlach H Ramsey G Levy M The surviving sepsis guidelines: Not another 'groundhog day' Crit Care Med 2004, 32:1601-1602. 10.1097/01.CCM.0000130996.14896.F6 15241108
15. Institute of Healthcare Improvement homepage http://www.IHI.org
16. Choi PT Yip G Quinonez LG Cook DJ Crystalloids vs. colloids in fluid resuscitation: A systematic review Crit Care Med 1999, 27:200-210. 10.1097/00003246-199901000-00053 9934917
17. Cook D Guyatt G Colloid use for fluid resuscitation: Evidence and spin Ann Intern Med 2001, 135:205-208. 11487488
18. Schierhout G Roberts I Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: A systematic review of randomised trials BMJ 1998, 316:961-964. 28497 9550953
19. Rackow EC Falk JL Fein IA Siegel JS Packman MI Haupt MT Kaufman BS Putnam D Fluid resuscitation in circulatory shock: A comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock Crit Care Med 1983, 11:839-850. 10.1097/00003246-198311000-00001 6194934
20. Finfer S Bellomo R Boyce N French J Myburgh J Norton R SAFE Study Investigators A comparison of albumin and saline for fluid resuscitation in the intensive care unit N Engl J Med 2004, 350:2247-2256. 10.1056/ NEJMoa040232 15163774
21. Bordin JO Heddle NM Blajchman MA Biologic effects of leukocytes present in transfused cellular blood products Blood 1994, 84:1703-1721. 8080981
22. Marik PE Sibbald WJ Effect of stored-blood transfusion on oxygen delivery in patients with sepsis JAMA 1993, 269:3024-3029. 10.1001/ jama.269.23.3024 8501845
23. Hebert PC Wells G Blajchman MA Marshall J Martin C Pagliarello G Tweeddale M Schweitzer I Yetisir E A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group N Engl J Med 1999, 340:409-417. 10.1056/NEJM199902113400601 9971864
24. De Backer D Creteur J Silva E Vincent JL Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: Which is best? Crit Care Med 2003, 31:1659-1667. 10.1097/ 01.CCM.0000063045.77339.B6 12794401
25. Marik PE Mohedin M The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis JAMA 1994, 272:1354-1357. 10.1001/jama.272.17.1354 7933396
26. Meier-Hellmann A Bredle DL Specht M Spies C Hannemann L Reinhart K The effects of low-dose dopamine on splanchnic blood flow and oxygen uptake in patients with septic shock Intensive Care Med 1997, 23:31-37. 10.1007/ s001340050287 9037637
27. Bellomo R Chapman M Finfer S Hickling K Myburgh J Low-dose dopamine in patients with early renal dysfunction: A placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group Lancet 2000, 356:2139-2143. 10.1016/ S0140-6736(00)03495-4 11191541
28. Kellum JA Decker MJ Use of dopamine in acute renal failure: A meta-analysis Crit Care Med 2001, 29:1526-1531. 10.1097/ 00003246-200108000-00005 11505120
29. Leone M Garnier F Bourgoin A Antonini F Martin C Renal effects of norepinephrine in septic and nonseptic patients Chest 2004, 126:534-539. 10.1378/chest.126.2.534 15302741
30. Bellomo R Kellum JA Wisniewski SR Pinsky MR Effects of norepinephrine on the renal vasculature in normal and endotoxemic dogs Am J Respir Crit Care Med 1999, 159:1186-1192. 10194164
31. Martin C Papazian L Perrin G Saux P Gouin F Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 1993, 103:1826-1831. 8404107
32. Martin C Viviand X Leone M Thirion X Effect of norepinephrine on the outcome of septic shock Crit Care Med 2000, 28:2758-2765. 10.1097/ 00003246-200008000-00012 10966247
33. Holmes CL Patel BM Russell JA Walley KR Physiology of vasopressin relevant to management of septic shock Chest 2001, 120:989-1002. 10.1378/ chest.120.3.989 11555538
34. Landry DW Levin HR Gallant EM Ashton RC Jr Seo S D'Alessandro D Oz MC Oliver JA Vasopressin deficiency contributes to the vasodilation of septic shock Circulation 1997, 95:1122-1125. 9054839
35. Landry DW Oliver JA The pathogenesis of vasodilatory shock N Engl J Med 2001, 345:588-595. 10.1056/NEJMra002709 11529214
36. Sharshar T Blanchard A Paillard M Raphael JC Gajdos P Annane D Circulating vasopressin levels in septic shock Crit Care Med 2003, 31:1752-1758. 10.1097/01.CCM.0000063046.82359.4A 12794416
37. Tsuneyoshi I Yamada H Kakihana Y Nakamura M Nakano Y Boyle WA III Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock Crit Care Med 2001, 29:487-493. 10.1097/ 00003246-200103000-00004 11373409
38. Malay MB Ashton RC Jr Landry DW Townsend RN Low-dose vasopressin in the treatment of vasodilatory septic shock J Trauma 1999, 47:699-703. discussion 703-705 10528604
39. Patel BM Chittock DR Russell JA Walley KR Beneficial effects of short-term vasopressin infusion during severe septic shock Anesthesiology 2002, 96:576-582. 10.1097/00000542-200203000-00011 11873030
40. van Haren FM Rozendaal FW van der Hoeven JG The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock Chest 2003, 124:2256-2260. 10.1378/chest.124.6.2256 14665508
41. Klinzing S Simon M Reinhart K Bredle DL Meier-Hellmann A High-dose vasopressin is not superior to norepinephrine in septic shock Crit Care Med 2003, 31:2646-2650. 10.1097/01.CCM.0000094260.05266.F4 14605537
42. Lopez A Lorente JA Steingrub J Bakker J McLuckie A Willatts S Brockway M Anzueto A Holzapfel L Breen D et al.: Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock Crit Care Med 2004, 32:21-30. 10.1097/01.CCM.0000105581.01815.C6 14707556
43. Parker MM Shelhamer JH Bacharach SL Green MV Natanson C Frederick TM Damske BA Parrillo JE Profound but reversible myocardial depression in patients with septic shock Ann Intern Med 1984, 100:483-490. 6703540
44. Vincent JL Gris P Coffernils M Leon M Pinsky M Reuse C Kahn RJ Myocardial depression characterizes the fatal course of septic shock Surgery 1992, 111:660-667. 1595062
45. Jardin F Sportiche M Bazin M Bourokba A Margairaz A Dobutamine: A hemodynamic evaluation in human septic shock Crit Care Med 1981, 9:329-332. 10.1097/00003246-198104000-00010 7214944
46. Tell B Majerus TC Flancbaum L Dobutamine in elderly septic shock patients refractory to dopamine Intensive Care Med 1987, 13:14-18. 10.1007/BF00263550 3558931
47. Vincent JL Roman A Kahn RJ Dobutamine administration in septic shock: addition to a standard protocol Crit Care Med 1990, 18:689-693. 10.1097/ 00003246-199007000-00001 2364708
48. Colardyn FC Vandenbogaerde JF Vogelaers DP Verbeke JH Use of dopexamine hydrochloride in patients with septic shock Crit Care Med 1989, 17:999-1003. 10.1097/00003246-198910000-00007 2791586
49. Hannemann L Reinhart K Meier-Hellmann A Wallenfang G Bredle DL Dopexamine hydrochloride in septic shock Chest 1996, 109:756-760. 8617087
50. Shoemaker WC Appel PL Kram HB Waxman K Lee TS Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients Chest 1988, 94:1176-1186. 3191758
51. Hayes MA Timmins AC Yau EH Palazzo M Hinds CJ Watson D Elevation of systemic oxygen delivery in the treatment of critically ill patients N Engl J Med 1994, 330:1717-1722. 10.1056/NEJM199406163302404 7993413